Mathieu Rosé

774 total citations
7 papers, 530 citations indexed

About

Mathieu Rosé is a scholar working on Surgery, Molecular Biology and Physiology. According to data from OpenAlex, Mathieu Rosé has authored 7 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in Mathieu Rosé's work include Cancer Research and Treatments (1 paper), Viral-associated cancers and disorders (1 paper) and Testicular diseases and treatments (1 paper). Mathieu Rosé is often cited by papers focused on Cancer Research and Treatments (1 paper), Viral-associated cancers and disorders (1 paper) and Testicular diseases and treatments (1 paper). Mathieu Rosé collaborates with scholars based in France, United States and Netherlands. Mathieu Rosé's co-authors include Nathalie Lassau, Sophie Leboulleux, Dana M. Hartl, Éric Baudin, Jean Paul Travagli, Elizabeth Girard, Bernard Caillou, Martin Schlumberger, Nadia Sabbah and Sandrine Rodriguez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mathieu Rosé

7 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Rosé France 7 324 317 91 69 55 7 530
L. Busutti Italy 11 218 0.7× 288 0.9× 117 1.3× 58 0.8× 42 0.8× 28 498
Jens Bentzen Denmark 12 266 0.8× 150 0.5× 195 2.1× 47 0.7× 41 0.7× 22 529
Bie‐Yu Huang Taiwan 12 315 1.0× 519 1.6× 99 1.1× 58 0.8× 114 2.1× 19 640
Tommaso Bizzarro Italy 14 376 1.2× 384 1.2× 149 1.6× 42 0.6× 52 0.9× 28 693
Howard H. Wu United States 14 337 1.0× 373 1.2× 134 1.5× 32 0.5× 57 1.0× 29 619
Patrizia Straccia Italy 16 424 1.3× 477 1.5× 146 1.6× 45 0.7× 85 1.5× 44 771
Timothy S. Greaves United States 10 154 0.5× 158 0.5× 71 0.8× 14 0.2× 52 0.9× 12 376
Marı́a Niveiro Spain 11 150 0.5× 123 0.4× 134 1.5× 14 0.2× 46 0.8× 35 413
Marija Us‐Krašovec Slovenia 13 160 0.5× 178 0.6× 163 1.8× 24 0.3× 33 0.6× 36 513
M Bodó Hungary 10 124 0.4× 157 0.5× 133 1.5× 22 0.3× 57 1.0× 32 498

Countries citing papers authored by Mathieu Rosé

Since Specialization
Citations

This map shows the geographic impact of Mathieu Rosé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Rosé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Rosé more than expected).

Fields of papers citing papers by Mathieu Rosé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Rosé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Rosé. The network helps show where Mathieu Rosé may publish in the future.

Co-authorship network of co-authors of Mathieu Rosé

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Rosé. A scholar is included among the top collaborators of Mathieu Rosé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Rosé. Mathieu Rosé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Fonseca, Eileen, Richard T. Silver, Lewis E. Kazis, et al.. (2013). Ruxolitinib Discontinuation In Patients With Myelofibrosis: An Analysis From Clinical Practice. Blood. 122(21). 2833–2833. 12 indexed citations
2.
Dômont, Julien, Christophe Massard, Anna Patrikidou, et al.. (2011). A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma. Urologic Oncology Seminars and Original Investigations. 31(5). 697–705. 21 indexed citations
3.
Missana, M.-C., Michel Germain, M. Spielman, et al.. (2007). Conservation aréolo-mamelonnaire en reconstruction mammaire immédiate : étude prospective de 66 cas. Journal de Chirurgie. 144(6). 516–521. 11 indexed citations
4.
Leboulleux, Sophie, Elizabeth Girard, Mathieu Rosé, et al.. (2007). Ultrasound Criteria of Malignancy for Cervical Lymph Nodes in Patients Followed Up for Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 92(9). 3590–3594. 358 indexed citations
5.
Magnon, Claire, Ariane Galaup, Valérie Rouffiac, et al.. (2006). Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration. Gene Therapy. 14(2). 108–117. 24 indexed citations
6.
Khabir, Abdelmajid, Héla Karray, Sandrine Rodriguez, et al.. (2005). EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. Virology Journal. 2(1). 39–39. 56 indexed citations
7.
Dômont, Julien, Timothy M. Pawlik, Valérie Boige, et al.. (2005). Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis. Journal of Clinical Oncology. 23(13). 3086–3093. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026